Abstract:Cell-substratum interactions trigger key signaling pathways that modulate growth control and tissue-specific gene expression. We have previously shown that abolishing adhesive interactions by suspension culture results in G(0) arrest of myoblasts. We report that blocking intracellular transmission of adhesion-dependent signals in adherent cells mimics the absence of adhesive contacts. We investigated the effects of pharmacological inhibitors of acto-myosin contractility on growth and differentiation of C2C12 myogenic cells. ML7 (5-iodonaphthalene-1-sulfonyl homopiperazine) and BDM (2,3, butanedione monoxime) are specific inhibitors of myosin light chain kinase, and myosin heavy chain ATPase, respectively. ML7 and BDM affected cell shape by reducing focal adhesions and stress fibers. Both inhibitors rapidly blocked DNA synthesis in a dose-dependent, reversible fashion. Furthermore, both ML7 and BDM suppressed expression of MyoD and myogenin, induced p27(kip1) but not p21(cip1), and inhibited differentiation. Thus, as with suspension-arrest, inhibition of acto-myosin contractility in adherent cells led to arrest uncoupled from differentiation. Over-expression of inhibitors of the small GTPase RhoA (dominant negative RhoA and C3 transferase) mimicked the effects of myosin inhibitors. By contrast, wild-type RhoA induced arrest, maintained MyoD and activated myogenin and p21 expression. The Rho effector kinase ROCK did not appear to mediate Rho's effects on MyoD. Thus, ROCK and MLCK play different roles in the myogenic program. Signals regulated by MLCK are critical, since inhibition of MLCK suppressed MyoD expression but inhibition of ROCK did not. Inhibition of contractility suppressed MyoD but did not reduce actin polymer levels. However, actin depolymerization with latrunculin B inhibited MyoD expression. Taken together, our observations indicate that actin polymer status and contractility regulate MyoD expression. We suggest that in myoblasts, the Rho pathway and regulation of acto-myosin contractility may define a control point for conditional uncoupling of differentiation and the cell cycle.

Actin-organizing protein palladin modulates C2C12 cell fate determination

Palladin Regulates Cell and Extracellular Matrix Interaction Through Maintaining Normal Actin Cytoskeleton Architecture and Stabilizing Beta1-Integrin

Stage-specific Effects of Notch Activation During Skeletal Myogenesis

Exploring the potential role of palladin in modulating human CAF/ECM functional units

Lacking of Palladin Leads to Multiple Cellular Events Changes Which Contribute to NTD

Target Deletion Of The Cytoskeleton-Associated Protein Palladin Does Not Impair Neurite Outgrowth In Mice

Palladin is a novel microtubule-associated protein responsible for spindle orientation

Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation

Atypical Peripheral Actin Band Formation Via Overactivation of RhoA and Nonmuscle Myosin II in Mitofusin 2-Deficient Cells

Palladin is involved in platelet activation and arterial thrombosis.

A Potential Regulatory Network Underlying Distinct Fate Commitment of Myogenic and Adipogenic Cells in Skeletal Muscle

Palladin Regulates Receptor Clustering and Actin Dynamics in Phagocytosis

Ccndbp1 is a New Positive Regulator of Skeletal Myogenesis

P21(cip1) and P57(kip2) Control Muscle Differentiation at the Myogenin Step.

Plectin Regulates Wnt Signaling Mediated-Skeletal Muscle Development by Interacting with Dishevelled-2 and Antagonizing Autophagy.

Anti-apoptotic protein Bcl-2 contributes to the determination of reserve cells during myogenic differentiation of C2C12 cells

Regulation of Heterochromatin Remodelling and Myogenin Expression During Muscle Differentiation by FAK Interaction with MBD2

Disruption Of Palladin Results In Neural Tube Closure Defects In Mice

LNC_000280 could be a new positive factor in the proliferation and differentiation of myoblasts: A prospective study

Adapting Cytoskeleton-Mitochondria Patterning with Myocyte Differentiation by Promyogenic PRR33

Ablation of palladin in adult heart causes dilated cardiomyopathy associated with intercalated disc abnormalities